Free Trial

Mural Oncology (MURA) SEC Filings & 10K Form

$3.75 -0.02 (-0.53%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$3.75 0.00 (0.00%)
As of 01/31/2025 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Mural Oncology SEC Filings

DateFilerForm TypeView
01/10/2025
6:00 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:19 PM
Keson-Brookes Maiken (Reporting)
Mural Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:06 PM
Loew Caroline (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
11:15 PM
Mural Oncology (Filer)
Form EFFECT
11/14/2024
2:18 PM
Mural Oncology (Subject)
Solas Capital Management, LLC (Filed by)
Form SCHEDULE 13G
11/13/2024
3:06 PM
Mural Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/13/2024
6:04 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:05 AM
Mural Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
2:52 PM
Mural Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
1:39 PM
Mural Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
6:04 AM
Cutler Adam D. (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
6:08 AM
Cutler Adam D. (Reporting)
Mural Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/26/2024
6:30 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
6:13 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:15 PM
ALTSCHULLER Susan (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:43 PM
ACORN BIOVENTURES, L.P. (Filed by)
Mural Oncology (Subject)
Form SCHEDULE 13G
08/13/2024
6:18 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
6:19 AM
Mural Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
12:02 PM
Mural Oncology (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
Form SC 13G/A
07/31/2024
3:02 PM
Golumbeski George (Reporting)
Mural Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2024
3:03 PM
Golumbeski George (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
6:20 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:04 PM
Keson-Brookes Maiken (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
8:42 PM
Mural Oncology (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
Form SC 13G/A
07/08/2024
7:01 PM
Loew Caroline (Reporting)
Mural Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/08/2024
7:03 PM
Loew Caroline (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Mural Oncology (Subject)
Form SC 13G/A
06/05/2024
3:10 PM
Jackson Scott Thomas (Reporting)
Mural Oncology (Issuer)
Form 4/A
06/05/2024
3:13 PM
Cuss Francis M (Reporting)
Mural Oncology (Issuer)
Form 4/A
06/05/2024
3:16 PM
Hickey Benjamin (Reporting)
Mural Oncology (Issuer)
Form 4/A
06/03/2024
9:20 AM
Cuss Francis M (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
9:23 AM
Hickey Benjamin (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
9:11 AM
ALTSCHULLER Susan (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
9:14 AM
Jackson Scott Thomas (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
6:04 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
6:06 AM
Mural Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
12:49 PM
Mural Oncology (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
Form SC 13G/A
04/12/2024
7:00 AM
Mural Oncology (Filer)
Form DEF 14A
04/12/2024
7:02 AM
Mural Oncology (Filer)
Form DEFA14A
04/12/2024
7:05 AM
Mural Oncology (Filer)
Form ARS
04/11/2024
8:10 PM
Loew Caroline (Reporting)
Mural Oncology (Issuer)
Form 4/A
Is this Elon’s true agenda? (Ad)

All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them

04/04/2024
7:56 PM
Mural Oncology (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
Form SC 13G/A
03/26/2024
3:42 PM
Mural Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
6:07 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:44 PM
ARMISTICE CAPITAL, LLC (Filed by)
Mural Oncology (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MURA) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners